Alain Hendlisz

Brussels, BRU, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 139 publications

5-Fluorouracil at seventy: still attractive but barely understood. A cautionary tale for drug development.

5-Fluorouracil at seventy: still attractive but barely understood. A cautionary tale for drug development.

Journal: Current opinion in oncology

Published: June 04, 2026

Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumours.

Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumours.

Journal: Current opinion in oncology

Published: June 04, 2026

Pain management in pancreatic cancer: time to change our strategy!

Pain management in pancreatic cancer: time to change our strategy!

Journal: Current opinion in oncology

Published: June 04, 2026

From dose to exposure? rethinking fluoropyrimidines as immune checkpoint partners in gastrointestinal cancers.

From dose to exposure? rethinking fluoropyrimidines as immune checkpoint partners in gastrointestinal cancers.

Journal: Current opinion in oncology

Published: June 03, 2026

Real-World Outcomes of [177Lu]Lu-DOTA-TATE Peptide Receptor Radionuclide Therapy in Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumors: Data from a Belgian ENETS Center of Excellence.

Real-World Outcomes of [177Lu]Lu-DOTA-TATE Peptide Receptor Radionuclide Therapy in Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumors: Data from a Belgian ENETS Center of Excellence.

Journal: Acta gastro-enterologica Belgica

Published: February 26, 2026

Are epigenetic-targeting approaches ready for prime time in neuroendocrine neoplasms?

Are epigenetic-targeting approaches ready for prime time in neuroendocrine neoplasms?

Journal: Current opinion in oncology

Published: May 27, 2025

Surgical management of pseudomyxoma peritonei: low-volume center experience.

Surgical management of pseudomyxoma peritonei: low-volume center experience.

Journal: Acta chirurgica Belgica

Published: May 21, 2025

Autophagy inhibition improves sensitivity to the multi-kinase inhibitor regorafenib in preclinical mouse colon tumoroids.

Autophagy inhibition improves sensitivity to the multi-kinase inhibitor regorafenib in preclinical mouse colon tumoroids.

Journal: Frontiers in cell and developmental biology

Published: May 19, 2025

Deep epigastric lymph node involvement in patients with ovarian and colorectal peritoneal metastasis: A prospective pilot study.

Deep epigastric lymph node involvement in patients with ovarian and colorectal peritoneal metastasis: A prospective pilot study.

Journal: Surgery

Published: May 12, 2025

Development and Validation of an 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography-Based Imaging Score to Predict 12-Week Life Expectancy in Advanced Chemorefractory Colorectal Cancer.

Development and Validation of an 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography-Based Imaging Score to Predict 12-Week Life Expectancy in Advanced Chemorefractory Colorectal Cancer.

Journal: JCO clinical cancer informatics

Published: April 30, 2025

Inflammation and mutational burden differentially associated with nivolumab or ipilimumab combination efficacy in colorectal cancer.

Inflammation and mutational burden differentially associated with nivolumab or ipilimumab combination efficacy in colorectal cancer.

Journal: Nature communications

Published: February 28, 2025

Management of high-grade neuroendocrine neoplasms: impact of functional imaging.

Management of high-grade neuroendocrine neoplasms: impact of functional imaging.

Journal: Endocrine-related cancer

Published: August 31, 2024

Showing 1-12 of 139

Last Updated: 09/26/2026